This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe
3-5 November 2026
Hotel Palace BerlinBerlin, Germany
Book Now
Menu
Book

Bo Wiinberg
Chief Business Development Officer at Novo Nordisk Foundation Cellerator
Speaker

Agenda Sessions

  • Funding the Future – Investor Panel Discussion: Investments in Cell and Gene Therapies and Enabling Technologies

    , 09:50
    View Session

At this event

Prev
Next
Sarah Snykers
Head of Site Strategy, Excellence and Build
Legend Biotech

See Bo at Cell & Gene Therapy International Europe

Book Now